Navigate

MindHub Academy 與廣州VV ART維維藝術創作合作

MindHub Academy 與廣州VV ART維維藝術創作合作，推出多樣藝術課程，啟發創意新潮流 香港 - Media OutReach - 2023å¹´10月23æ—¥ - 在這個充滿活力的城市，一個令人振奮的消息即將在藝術界掀起巨浪。MindHub Academy 和⌈廣州VV ART維維藝術創作…

3 years ago

Covation Holdings Continues Expansion in Asia Pacific With New Regional Corporate Headquarters

HONG KONG--(BUSINESS WIRE)--Covation Holdings Limited, the global manufacturer of multiple wheeled goods brands, today announced…

3 years ago

Berkshire Hathaway Specialty Insurance Names Sami Jaghbir as Underwriting Manager in Queensland

BRISBANE, Australia & BOSTON--(BUSINESS WIRE)--Berkshire Hathaway Specialty Insurance (BHSI) today announced that it has appointed…

3 years ago

Groundbreaking EV-302 Trial Significantly Extends Overall Survival and Progression-Free Survival in Patients Treated with PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) in First-Line Advanced Bladder Cancer

– Risk of death was reduced by 53% in patients treated with enfortumab vedotin plus…

3 years ago

Raludotatug Deruxtecan Continues to Demonstrate Promising Clinical Activity in Patients with Advanced Ovarian Cancer in Early Trial

Encouraging overall response rate of 46% and disease control rate of 98% with a median…

3 years ago

Correcting and Replacing: Lighting the Way to the Future: Renowned Brands Unveil Breakthroughs in the World-Renowned Lighting Marketplace

Buyer Registration Link HONG KONG SAR - Media OutReach - 22 October 2023 - Organised…

3 years ago

Datopotamab Deruxtecan Plus Durvalumab Demonstrated Robust and Durable Tumor Responses in First-Line Treatment of Patients with Metastatic Triple Negative Breast Cancer in BEGONIA Phase 1b/2 Trial

Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan plus durvalumab showed a confirmed objective response rate of…

3 years ago

CHNT Group Showed at The 24th Conference on The Electric Power Supply Industry

XIAMEN, China--(BUSINESS WIRE)--On October 20th, the 24th Conference on The Electric Power Supply Industry kicked…

3 years ago

MakeMyTrip Limited to report Fiscal 2024 Second Quarter Financial & Operating Results on October 31, 2023

GURUGRAM, India & NEW YORK--(BUSINESS WIRE)--$MMYT #Fiscal2024--MakeMyTrip Limited (Nasdaq: MMYT) plans to report its fiscal…

3 years ago

Foundation Medicine Expands Partnership with Sequanta to Provide both Liquid and Tissue Genomic Profiling Services in China to Support Global Regulatory Filings

Foundation Medicine will transfer FoundationOne®Liquid CDx technology to Sequanta in November 2023 and FoundationOne®CDx technology…

3 years ago

Search